Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
393
datasets available to search
ShareScore release 0.9.0
Dataset results
393 results for “Recurrent glioma”
Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
ClinicalTrials.gov study NCT02359565. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma
ClinicalTrials.gov study NCT00024570. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Acetazolamide With Temozolomide in Adults With Newly Diagnosed or Recurrent Malignant Glioma
ClinicalTrials.gov study NCT03011671. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Carboplatin, Temozolomide, and Filgrastim in Treating Patients With Newly Diagnosed or Recurrent High-Grade Glioma
ClinicalTrials.gov study NCT00006263. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma
ClinicalTrials.gov study NCT06585527. IPD Sharing: NO. Countries: 1. Publications: 0.
Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas
ClinicalTrials.gov study NCT00083096. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma
ClinicalTrials.gov study NCT00005951. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Patients With Recurrent Grade 4 Glioma and Patients With Brain Metastases
ClinicalTrials.gov study NCT07268053. IPD Sharing: NO. Countries: 1. Publications: 0.
Irinotecan Liposomes Combined With Bevacizumab in the Treatment of Recurrent Glioma
ClinicalTrials.gov study NCT06801730. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients
ClinicalTrials.gov study NCT05182905. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade Glioma
ClinicalTrials.gov study NCT00213278. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Application of Palliative Treatment in Children With Brain Stem Glioma and Recurrent High-grade Tumors in the Central Nervous System With the Nanomaterial NPt-Ca
ClinicalTrials.gov study NCT03250520. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery
ClinicalTrials.gov study NCT02031965. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ph 1/2 CTO With Lomustine for Bevacizumab-Naive Recurrent Glioma
ClinicalTrials.gov study NCT01989052. IPD Sharing: Not stated. Countries: 1. Publications: 0.
5-ALA in Recurrent Glioma
ClinicalTrials.gov study NCT02119338. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Personalized Vaccine for Patients With Recurrent Malignant Glioma
ClinicalTrials.gov study NCT04943718. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PTCs-based Precision Treatment Strategy on Recurrent High-grade Gliomas
ClinicalTrials.gov study NCT05473923. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas
ClinicalTrials.gov study NCT05609994. IPD Sharing: NO. Countries: 1. Publications: 0.
The Efficacy of APT Magnetic Resonance Imaging in Predicting the Efficacy of Bevacizumab in Recurrent Malignant Gliomas
ClinicalTrials.gov study NCT03180697. IPD Sharing: NO. Countries: 1. Publications: 0.
LITT Followed by Hypofractionated RT for Recurrent Gliomas
ClinicalTrials.gov study NCT04181684. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.